Successful Management of a Patient with Refractory Primary Central Nervous System Lymphoma by Zanubrutinib

Cheng Q, Wang J, Lv C, Xu J

OncoTargets and Therapy 2021, 14:3367-3372

Published Date: 24 May 2021